|
Take a peek inside the brain with prize-winning artwork inspired by research at The Ottawa Hospital
July 6, 2023
-
Patients, visitors and staff at TOH’s General Campus can now experience what it might be like to float through the human brain, thanks to a unique collaboration between local artist Svetlana Swinimer and neuroscientist Dr. Michael Schlossmacher.
|
|
Discovery reveals how Parkinson’s-linked gene protects the brain
April 5, 2023
-
For more than 20 years, researchers have known that young-onset Parkinson’s disease is often caused by mutations in the parkin gene, but the exact function of this gene has been hotly debated.
|
|
Predicting Parkinson’s: mathematical model could help with earlier diagnosis and treatment
September 23, 2022
-
An innovative mathematical model developed by researchers at The Ottawa Hospital could one day help with the prevention and early treatment of Parkinson’s disease.
|
Show more news stories
|
|
The Ottawa Hospital’s push to demystify Parkinson’s disease
April 29, 2022
-
Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s, affecting at least 100,000 Canadians. Researchers at The Ottawa Hospital are on the global stage seeking answers for patients desperately waiting for a breakthrough.
|
|
Meet Dr. Michael Schlossmacher
April 29, 2022
-
Growing up in Austria, Dr. Michael Schlossmacher couldn’t have foreseen his future as a physician-scientist conducting groundbreaking Parkinson’s research at The Ottawa Hospital.
|
|
Meet Parkinson’s researcher Dr. Julianna Tomlinson
April 29, 2022
-
Born, raised, educated, and trained in Ottawa, Dr. Julianna Tomlinson is using research to change the way we think about Parkinson’s disease.
|
|
The Ottawa Hospital Joins Michael J. Fox Foundation’s Expansion of the Parkinson’s Progression Markers Initiative (PPMI), Landmark Study toward Better Treatments and Prevention of Disease
March 3, 2022
-
The Ottawa Hospital aims to enroll people recently diagnosed with Parkinson’s who are not yet taking medication and individuals over age 60 with certain risk factors in the Parkinson’s Progression Markers Initiative (PPMI),
|
|
Does Parkinson’s start in the nose? International team awarded US$9 million ASAP grant to find out
October 26, 2021
-
More than 80 percent of people with Parkinson’s disease suffer from a reduced sense of smell, something that often occurs years before the onset of typical movement-related symptoms. Now, thanks to a US$9 million grant from the Aligning Science Acros
|
|
Experts on call: Parkinson’s care and research
April 22, 2021
-
Topics of discussion will include recently approved Parkinson’s drugs, Duodopa pump treatment and progress in understanding early-onset Parkinson’s.
|
|
Parkinson’s discovery points to possible future treatment approaches
April 6, 2021
-
More than 20 years after the discovery of the parkin gene linked to young-onset Parkinson’s disease, researchers at The Ottawa Hospital and the University of Ottawa may have finally figured out how this mysterious gene protects the brain.
|
|
Drug can treat Parkinson’s-related drooling, study shows
October 21, 2020
-
An Ontario study led by Dr. Tiago Mestre provides the first longer-term evidence that glycopyrrolate can reduce drooling associated with Parkinson’s disease.
|
|
Two researchers at The Ottawa Hospital receive Ontario Early Researcher Awards
September 1, 2020
-
Two researchers from The Ottawa Hospital affiliated with the University of Ottawa received Early Researcher Awards from the Ontario Research Fund.
|
|
Decoding the mystery of Parkinson’s disease
July 10, 2020
-
For more than 200 years, no one has been able to solve the Parkinson puzzle. While the exact cause of the disease remains a mystery, dedicated researchers at The Ottawa Hospital are gaining ground—determined to solve the puzzle.
|
|
New Frontiers in Research Fund supports trailblazing research on autism, Alzheimer’s, Parkinson’s
June 3, 2020
-
Researchers from The Ottawa Hospital are involved in four new projects funded through the Exploration stream of Canada’s New Frontiers in Research Fund. The fund is designed to support high-risk, high-reward and interdisciplinary research.
|
|
Unravelling the mystery of how one gene contributes to Parkinson’s, Crohn’s and leprosy
September 25, 2019
-
Researchers have struggled for years to understand how mutations in one gene, called LRRK2, can increase the risk of three very different diseases: Parkinson’s (a brain disease), Crohn’s (a gut disease) and leprosy (a peripheral nervous system diseas
|
|
Clinical trials offer strong foundation for better patient care
May 16, 2019
-
Clinical trials are an important step toward developing new treatments and learning more about diseases and conditions. In honour of International Clinical Trials Day, read how some of the researchers at The Ottawa Hospital are making huge contribut
|
|
Researchers honoured for outstanding work in Parkinson’s, critical care and surgery
April 11, 2019
-
A number of outstanding researchers and research teams were recognized at The Ottawa Hospital’s Excellence Awards Ceremony on April 11. They include the Parkinson Research Consortium, the Operating Room Black Box® Research Program and ICU resear
|
|
Researcher brings made-in-Ottawa approach to Parkinson’s care to Europe
March 15, 2019
-
A personalized approach for Parkinson’s care pioneered in Ottawa will soon be tested in Europe, thanks to a prestigious $2.2 M grant. This approach, called the Integrated Parkinson’s Care Network, was developed by Drs. Tiago Mestre and David Grimes.
|
|
Brain Health Awareness Week: October 15-19
October 10, 2018
-
Researchers, clinicians, patients and members of the general public are invited to take part in Brain Health Awareness Week from October 5-19, hosted by the University of Ottawa Brain and Mind Research Institute, in collaboration with The Ottawa Hosp
|
|
Researchers to test patient-centered approach to Parkinson’s care
December 15, 2017
-
Dr. Tiago Mestre has received a $197,000 New Investigator Award from the Physicians’ Services Incorporated Foundation to test a new model of care for people living with Parkinson’s disease. This project, called the Integrated Parkinson’s Care Network
|
|
Award-winning scientist challenges medical dogma in quest to prevent, treat neurodegenerative disease
October 25, 2017
-
Dr. Michael Schlossmacher grew up in Austria, trained at Harvard and now leads The Ottawa Hospital’s neuroscience research program. His research helped establish a key concept in Alzheimer’s disease and led to a clinical trial of an experimental ther
|
|
The Ottawa Hospital awarded 18 research grants from the Canadian Institutes of Health Research, worth $10.7 million
May 19, 2017
-
Eighteen research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded nearly $11 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). This represents a suc
|
|
Levodopa pumps new life into Ottawa Parkinson’s patient
March 31, 2016
-
Retired teacher Nick Kaethler, now 75, was the first person in Ottawa to receive a newly approved treatment for advanced Parkinson’s disease that delivers drugs directly to the small intestine. He said the pump has reduced his symptoms and given
|
|
Deep-brain stimulation brings a family doctor with Parkinson’s back from “the abyss”
June 30, 2015
-
Doctors aren’t known for their great handwriting skills, but this was more than just bad handwriting. Dr. Jacques Theriault’s writing got smaller as he moved across the page. It was 2006 when he first noticed the problem, and while most people might
|
|
Weston grants to accelerate development of new therapies for Parkinson disease and related dementias
November 26, 2014
-
Drs. Michael Schlossmacher and Julianna Tomlinson and their colleagues have been awarded $300,000 from the Weston Brain Institute for two research projects aimed at developing new therapies for Parkinson disease and dementia with Lewy bodies. These p
|